Table 2. Prevalence of multimorbidity (including CKD) in the OxREN cohort stratified by sex and whether they had CKD.
Number of comorbidities | Full cohort (n = 861) | Women (n = 468) | Men (n = 393) | CKD (n = 584) | CKD (not including CKD co-morbidity | No CKD (n = 277) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | % (95%CI) | N | % (95%CI) | N | % (95%CI) | N | % (95%CI) | N, % (95%CI) | N | % (95%CI) | |
0 | 51 | 6% (4–8) | 29 | 6% (4–8) | 22 | 6% (3–8) | 0 | - | 78, 13% (10–16) | 51 | 18% (14–23) |
1 | 174 | 20% (18–23) | 101 | 22% (18–25) | 73 | 19% (15–22) | 78 | 13% (11–16) | 154, 26% (22–30) | 96 | 35% (29–40) |
2 | 231 | 27% (24–30) | 127 | 27% (23–31) | 104 | 26% (22–31) | 154 | 26% (23–30) | 144, 25% (20–30) | 77 | 28% (23–33) |
3 | 178 | 21% (18–23) | 104 | 22% (18–26) | 74 | 19% (15–23) | 144 | 25% (21–28) | 100, 17% (13–21) | 34 | 12% (8–16) |
4 | 108 | 13% (10–15) | 49 | 10% (8–13) | 59 | 15% (11–19) | 100 | 17% (14–20) | 71, 12% (9–15) | 8 | 3% (1–5%) |
5 or more | 119 | 14% (12–16) | 58 | 12% (9–15) | 61 | 16% (12–19) | 108 | 18% (15–22) | 37, 6% (4–8) | 11 | 4% (2–6) |